Sorafenib and pulmonary embolism 
Sorafenib and pulmonary embolism Patient Reports March 20, 2010
Sorafenib Side Effects Report #5978303-9
Sorafenib side effect was reported by a Physician from ITALY on Nov 26, 2008. Male patient, 53 years of age, weighting 141.1 lb, was diagnosed with sarcoma, prophylaxis, nausea
, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with OMEPRAZOLE, DOMPERIDONE, TRAMADOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6091345-0
Sorafenib side effect was reported by a Physician from ITALY on Feb 18, 2009. Male patient, 53 years of age, weighting 141.1 lb, was diagnosed with sarcoma, prophylaxis, nausea
, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with OMEPRAZOLE, DOMPERIDONE, TRAMADOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6080256-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Female patient, 62 years of age, weighting 191.8 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: breast pain, dyspnoea, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ESTRADIOL, THYROID, REGLAN, FERROUS GLUCONATE, PROTONIX. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5623368-7
Sorafenib side effect was reported by a Physician from GERMANY on Feb 07, 2008. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disturbance in attention, dyspnoea, fatigue, oedema peripheral, pleural effusion, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with TORSEMIDE, PANTOPRAZOL, HYDROXYMORPHIN, CIPRAMIL, FLUNITRAZEPAM. Patient was hospitalized. Patient died on 12/26/2007.Sorafenib Side Effects Report #5625706-8
Sorafenib side effect was reported by a Physician from GERMANY on Feb 06, 2008. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, disturbance in attention, dyspnoea, fatigue, oedema peripheral, pleural effusion, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with TORSEMIDE, PANTOPRAZOL, HYDROXYMORPHIN, CIPRAMIL, FLUNITRAZEPAM. Patient was hospitalized. Patient died on 12/26/2007.Sorafenib Side Effects Report #6020861-2
Sorafenib side effect was reported by a Physician from GERMANY on Dec 18, 2008. Male patient, 53 years of age, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: unknown. Patient recovered.Sorafenib Side Effects Report #6052770-7
Sorafenib side effect was reported by a Physician from GERMANY on Jan 21, 2009. Male patient, 53 years of age, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: metastases to lung, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 1200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6120576-6
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2009. Male patient, weighting 223.0 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fatigue, pulmonary embolism
. Sorafenib dosage: 400 MG PO BID. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5349060-4
Sorafenib side effect was reported by a Physician from GERMANY on May 21, 2007. Male patient, 84 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pancytopenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5452545-3
Sorafenib side effect was reported by a Physician from GERMANY on Sept 11, 2007. Male patient, 84 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pancytopenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5660864-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 84 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pancytopenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5873574-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 02, 2008. Male patient, 84 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pancytopenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5990191-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Male patient, 84 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pancytopenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5883654-2
Sorafenib side effect was reported by a Physician from CANADA on Sept 09, 2008. Male patient, 74 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer stage iv, prophylaxis against transplant rejection, urinary retention, dyspepsia, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CYCLOSPORINE, PREDNISONE, FLOMAX, RANITIDINE, TYLENOL. Patient recovered.Sorafenib Side Effects Report #5890527-8
Sorafenib side effect was reported by a Physician from CANADA on Sept 17, 2008. Male patient, 74 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer stage iv, prophylaxis against transplant rejection, urinary retention, dyspepsia, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CYCLOSPORINE, PREDNISONE, FLOMAX, RANITIDINE, TYLENOL. Patient recovered.Sorafenib Side Effects Report #5916038-9
Sorafenib side effect was reported by a Physician from CANADA on Oct 08, 2008. Male patient, 74 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer stage iv, prophylaxis against transplant rejection, urinary retention, dyspepsia, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CYCLOSPORINE, PREDNISONE, FLOMAX, RANITIDINE, TYLENOL. Patient recovered.Sorafenib Side Effects Report #4889341-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Male patient, 75 years of age, weighting 221.3 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, thrombosis. Sorafenib dosage: 400 MG BID ORAL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4898058-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 75 years of age, weighting 221.3 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypoxia, malignant neoplasm progression, pulmonary embolism
, thrombosis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ASPIRIN, LOFIBRA, MORPHINE SULPHATE, ACCUPRIL, DEXAMETHASONE, FOLIC ACID, ZOCOR. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5098595-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 29, 2006. Male patient, 80 years of age, weighting 187.4 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
, pulmonary thrombosis. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5815882-6
Sorafenib side effect was reported by a Physician from SPAIN on July 14, 2008. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer, prophylaxis against bronchospasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypovolaemic shock, pulmonary embolism
, upper gastrointestinal haemorrhage. Sorafenib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, PLUSVENT, COMBIVENT, SUTRIL, ESPIRONOLACTONA, SPIRIVA. Patient was hospitalized. Patient died on 06/09/2008.Sorafenib Side Effects Report #5980332-6
Sorafenib side effect was reported by a Physician from NETHERLANDS on Dec 02, 2008. Male patient, 71 years of age, weighting 198.4 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMZAR, CISPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6119074-5
Sorafenib side effect was reported by a Physician from NETHERLANDS on Mar 12, 2009. Male patient, 71 years of age, weighting 198.4 lb, was diagnosed with non-small cell lung cancer, glaucoma
, thrombosis prophylaxis, dyspnoea, prophylaxis of nausea and vomiting, diarrhoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMZAR, CISPLATIN, TIMOPTIC, FRAXIPARIN, FORADIL, OXAZEPAM, PRIMPERAN, IMODIUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5509839-2
Sorafenib side effect was reported by a Physician from ITALY on Oct 31, 2007. Male patient, 69 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis of nausea and vomiting, pulmonary embolism
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN, PLASIL, DEXAMETHASONE, COUMADIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5180973-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, chest pain
, chronic obstructive pulmonary disease, facial pain, headache , pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5368787-1
Sorafenib side effect was reported by a Physician from NETHERLANDS on June 20, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer, dyspepsia, cardiac disorder, pain
, benign prostatic hyperplasia, nervousness, bronchitis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: febrile neutropenia, pulmonary embolism . Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PANTOZOL, ATENOLOL, GABAPENTIN, OMNIC, DIAZEPAM, ATROVENT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5246571-7
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2007. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PARACETAMOL, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #5262437-0
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Mar 06, 2007. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ACETAMINOPHEN, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #6017554-4
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2008. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesia, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ACETAMINOPHEN, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #6056444-8
Sorafenib side effect was reported by a Physician from NETHERLANDS on Jan 22, 2009. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer, anxiety
, anaemia prophylaxis, prophylaxis of nausea and vomiting, hypokalaemia, oxygen saturation decreased and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: diabetes mellitus, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMZAR, OXAZEPAM, EPREX, PRIMPERAN, POTASSIUM CHLORIDE, OXYGEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6062521-8
Sorafenib side effect was reported by a Physician from NETHERLANDS on Feb 02, 2009. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer, anxiety
, anaemia prophylaxis, prophylaxis of nausea and vomiting, hypokalaemia, oxygen saturation decreased and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: diabetes mellitus, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMZAR, OXAZEPAM, EPREX, PRIMPERAN, POTASSIUM CHLORIDE, OXYGEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6130830-X
Sorafenib side effect was reported by a Physician from NETHERLANDS on Mar 24, 2009. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer, prophylaxis, anaemia prophylaxis, prophylaxis of nausea and vomiting and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: diabetes mellitus, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMZAR, OXAZEPAM, EPREX, PRIMPERAN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5324163-9
Sorafenib side effect was reported by a Physician from UNITED STATES on May 09, 2007. Male patient, 60 years of age, weighting 233.7 lb, was diagnosed with non-small cell lung cancer, arthralgia, vitamin supplementation, prophylaxis, mucosal inflammation and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, VICODIN, VITAMIN B6, TYLENOL EXTRA STRENGTH, UDDER BALM, XYLOCAINE VISCOUS. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5333648-0
Sorafenib side effect was reported by a Physician from UNITED STATES on May 09, 2007. Male patient, 60 years of age, weighting 233.7 lb, was diagnosed with non-small cell lung cancer, arthralgia, vitamin supplementation, prophylaxis, mucosal inflammation and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, VICODIN, VITAMIN B6, TYLENOL EXTRA STRENGTH, UDDER BALM, XYLOCAINE VISCOUS. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5212788-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 17, 2007. Female patient, 59 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, non-small cell lung cancer, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 01/03/2007.Sorafenib Side Effects Report #5121559-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 21, 2006. Female patient, 59 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5907046-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 24, 2008. Female patient, 59 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, ATENOLOL. Patient recovered.Sorafenib Side Effects Report #5913222-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 07, 2008. Female patient, 59 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, ATENOLOL. Patient recovered.Sorafenib Side Effects Report #6125552-5
Sorafenib side effect was reported by a Physician from GERMANY on Mar 16, 2009. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer, nausea
, chronic obstructive pulmonary disease and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: nausea , pulmonary embolism . Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, METOCLOPRAMIDE, CHLORIDE, VOMEX A, SPIRIVA, BERODUAL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5216972-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypoxia, lung infiltration, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient died on 01/18/2007.Sorafenib Side Effects Report #5220589-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypoxia, lung infiltration, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient died on 01/18/2007.Sorafenib Side Effects Report #5541499-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 07, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypoxia, lung infiltration, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient died on 01/18/2007.Sorafenib Side Effects Report #5585256-4
Sorafenib side effect was reported by a Physician from CHINA on Dec 07, 2007. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5610844-6
Sorafenib side effect was reported by a Physician from CHINA on Jan 31, 2008. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient died on 12/19/2007.Sorafenib Side Effects Report #5652891-4
Sorafenib side effect was reported by a Physician from CHINA on Mar 04, 2008. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: non-small cell lung cancer, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient died on 12/19/2007.Sorafenib Side Effects Report #5890501-1
Sorafenib side effect was reported by a Physician from CHINA on Sept 19, 2008. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: non-small cell lung cancer, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 12/19/2007.Sorafenib Side Effects Report #6081582-3
Sorafenib side effect was reported by a Physician from CHINA on Feb 17, 2009. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: non-small cell lung cancer, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 12/19/2007.Sorafenib Side Effects Report #5747411-X
Sorafenib side effect was reported by a Physician from SPAIN on May 13, 2008. Male patient, weighting 152.1 lb, was diagnosed with non-small cell lung cancer, prophylaxis against bronchospasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, PLUSVENT, COMBIVENT, SUTRIL, ESPIRONOLACTONA, SPIRIVA. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5071829-4
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on July 25, 2006. Male patient, 82 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, pulmonary embolism
. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5106467-8
Sorafenib side effect was reported by a Physician from FRANCE on May 24, 2006. Male patient, 82 years of age, weighting 138.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5019999-8
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on May 24, 2006. Male patient, 82 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, pulmonary embolism
. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4891891-9
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2006. Male patient, 80 years of age, weighting 170.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, pulmonary thrombosis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with AVAPRO, MICRONASE, ACIPHEX, PLAVIX, PROZAC, CRESTOR, MEGACE, XALATAN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4898181-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 23, 2006. Male patient, 80 years of age, weighting 170.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: immobile, pulmonary embolism
. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with AVAPRO, MICRONASE, ACIPHEX, PLAVIX, PROZAC, CRESTOR, MEGACE, XALATAN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5216975-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 19, 2006. Female patient, 78 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma, pulmonary embolism
, gastrooesophageal reflux disease, hypertension, hypothyroidism, nausea , pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, fall , gastrointestinal haemorrhage, haemorrhoids, hip fracture, hypotension, pulmonary embolism , supraventricular tachycardia, syncope. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN, PROTONIX, DIOVAN, LEVOTHYROXINE, COMPAZINE, VICODIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5223821-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 14, 2006. Female patient, 78 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma, pulmonary embolism
, gastrooesophageal reflux disease, hypertension, hypothyroidism, nausea , pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, fall , gastrointestinal haemorrhage, hip fracture, pulmonary embolism , supraventricular tachycardia, syncope. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN, PROTONIX, DIOVAN, LEVOTHYROXINE, COMPAZINE, VICODIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4961102-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, 77 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, blood alkaline phosphatase increased, chest discomfort, chest pain
, creatine phosphokinase decreased, decreased appetite, hypotension, pulmonary embolism , rash . Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DILTIAZEM, LESCOL, AMBIEN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5208726-7
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Jan 03, 2007. Male patient, 74 years of age, weighting 194.0 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, cardiomyopathy
, hyperlipidaemia, anaemia, anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bronchospasm, cough, deep vein thrombosis , dry skin, international normalised ratio increased, pneumonia primary atypical, pulmonary embolism , rash erythematous, skin exfoliation. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MONOPRIL, TOPROL, ZOCOR, FERROUS SULPHATE, ATIVAN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5118429-5
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Jan 09, 2006. Male patient, 74 years of age, weighting 194.0 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, cardiomyopathy
, hyperlipidaemia, anaemia, anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bronchospasm, cough, deep vein thrombosis , dry skin, international normalised ratio increased, pulmonary embolism , rash erythematous, skin exfoliation, stridor. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with MONOPRIL, TOPROL, ZOCOR, FERROUS SULPHATE, ATIVAN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5075080-3
Sorafenib side effect was reported by a Physician from FRANCE on July 25, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood pressure increased, hepatic cyst, pulmonary artery thrombosis, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, OLMETEC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5129532-8
Sorafenib side effect was reported by a Physician from FRANCE on July 25, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood pressure increased, hepatic cyst, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5375994-0
Sorafenib side effect was reported by a Physician from FRANCE on June 25, 2007. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4782290-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 14, 2005. Female patient, 58 years of age, weighting 207.2 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood pressure increased, fibrin d dimer increased, heart rate increased, insomnia, pulmonary embolism
, respiratory rate increased, thrombosis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with COMPAZINE, FIBER S, OXYCODONE, KEFLEX, TUCKS, COLACE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5027382-4
Sorafenib side effect was reported by a Physician from UNITED STATES on June 05, 2006. Female patient, 58 years of age, weighting 207.2 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood pressure increased, heart rate increased, pulmonary embolism
. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DTIC, COMPAZINE, OXYCODONE, KEFLEX, TUCKS, COLACE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5029889-2
Sorafenib side effect was reported by a Physician from UNITED STATES on June 05, 2006. Female patient, 58 years of age, weighting 207.2 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood pressure increased, heart rate increased, poor quality sleep, prothrombin time prolonged, pulmonary embolism
, respiratory rate increased. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, COMPAZINE, OXYCODONE, KEFLEX, TUCKS, COLACE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5104434-1
Sorafenib side effect was reported by a Physician from FRANCE on Aug 01, 2006. Male patient, 46 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, deep vein thrombosis , hepatomegaly, pulmonary embolism , sinus tachycardia, thrombophlebitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, SKENAN, MORPHINE SULPHATE, DUPHALAC, ATARAX, LEXOMIL. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5276721-8
Sorafenib side effect was reported by a Physician from FRANCE on Mar 21, 2007. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, SKENAN, ACTISKENAN, DUPHALAC, ATARAX, LEXOMIL, MORPHINE. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5141064-X
Sorafenib side effect was reported by a Physician from FRANCE on Aug 01, 2006. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, SKENAN, ACTISKENAN, DUPHALAC, ATARAX, LEXOMIL, MORPHINE. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5392069-5
Sorafenib side effect was reported by a Physician from FRANCE on July 16, 2007. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SKENAN, ACTISKENAN, DUPHALAC, ATARAX, LEXOMIL, MORPHINE. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5793747-6
Sorafenib side effect was reported by a Physician from FRANCE on June 20, 2008. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, SKENAN, MORPHINE, DUPHALAC, ATARAX, LEXOMIL. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5795843-6
Sorafenib side effect was reported by a Physician from FRANCE on June 20, 2008. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, SKENAN, MORPHINE, DUPHALAC, ATARAX, LEXOMIL. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5501664-1
Sorafenib side effect was reported by a Physician from CANADA on Oct 25, 2007. Male patient, 72 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant, hypertension, insomnia, back pain
, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MICARDIS, ATIVAN, TYLENOL W, ALLOPURINOL, FENTANYL CITRATE, MORPHINE. Patient was hospitalized. Patient died on 09/24/2007.Sorafenib Side Effects Report #5515910-1
Sorafenib side effect was reported by a Physician from CANADA on Nov 08, 2007. Male patient, 72 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant, hypertension, insomnia, back pain
, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hepatic failure, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MICARDIS, ATIVAN, TYLENOL W, ALLOPURINOL, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 09/24/2007.Sorafenib Side Effects Report #5578975-7
Sorafenib side effect was reported by a Physician from CANADA on Dec 21, 2007. Male patient, 72 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant, hypertension, insomnia, back pain
, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hepatic failure, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MICARDIS, ATIVAN, TYLENOL W, ALLOPURINOL, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 09/24/2007.Sorafenib Side Effects Report #5700133-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 07, 2008. Male patient, 72 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant, hypertension, insomnia, back pain
, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hepatic failure, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MICARDIS, ATIVAN, TYLENOL W, ALLOPURINOL, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 09/24/2007.Sorafenib Side Effects Report #6122304-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 27, 2009. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with ENTECAVIR. Patient recovered.Sorafenib Side Effects Report #5127515-5
Sorafenib side effect was reported by a Physician from ITALY on Oct 04, 2006. Female patient, 56 years of age, weighting 130.1 lb, was diagnosed with bile duct cancer, prophylaxis, pain
, anaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with LANSOX, DELTACORTENETE, NEORECORMON. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6073502-2
Sorafenib side effect was reported by a Physician from FRANCE on Feb 04, 2009. Female patient, 60 years of age, weighting 220.5 lb, was diagnosed with angiosarcoma, osteoarthritis
, hypertension, parkinson's disease and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pelvic venous thrombosis, pulmonary embolism , tumour haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with ATENOLOL, HYTACAND, LAMALINE, SIFROL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6081585-9
Sorafenib side effect was reported by a Physician from FRANCE on Feb 10, 2009. Female patient, 60 years of age, weighting 220.5 lb, was diagnosed with angiosarcoma, osteoarthritis
, hypertension, parkinson's disease , thrombosis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pelvic venous thrombosis, pulmonary embolism , therapeutic embolisation, tumour haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with ATENOLOL, HYTACAND, LAMALINE, SIFROL, OMEPRAZOLE, HEPARIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4951849-8
Sorafenib side effect was reported by a Consumer or non-health professional from POLAND on Mar 12, 2006. Female patient, 75 years of age, weighting 134.5 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with VERAPAMIL, DOPEGYT, METOCARD, ZOCOR. Patient died on 01/11/2006.Sorafenib Side Effects Report #4996193-8
Sorafenib side effect was reported by a Consumer or non-health professional from POLAND on Apr 19, 2006. Female patient, 75 years of age, weighting 134.5 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with VERAPAMIL, DOPEGYT, METOCARD, ZOCOR. Patient died on 01/11/2006.Sorafenib Side Effects Report #5739109-9
Sorafenib side effect was reported by a Physician from CANADA on May 08, 2008. Male patient, 74 years of age, weighting 119.0 lb, was diagnosed with lung transplant rejection, urinary retention, dyspepsia, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CYCLOSPORINE, PREDNISONE, FLOMAX, RANITIDINE, TYLENOL. Patient recovered.Sorafenib Side Effects Report #5451139-3
Sorafenib side effect was reported by a Physician from NETHERLANDS on Sept 07, 2007. Male patient, 71 years of age, weighting 145.5 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with LACTULOSE, VALORON, ZOMETA, CALCITRIOL, PHOSEX, MANYPER, FUCIDINE, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5262227-9
Sorafenib side effect was reported by a Consumer or non-health professional from GERMANY on Mar 06, 2007. Male patient, 70 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dysphonia, fatigue, pain in extremity, pulmonary embolism
, vomiting. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient died on 01/09/2007.Sorafenib Side Effects Report #5252839-0
Sorafenib side effect was reported by a Physician from NETHERLANDS on Feb 21, 2007. Male patient, 63 years of age, weighting 163.1 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cancer pain, chest pain
, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with DURAGESIC, DICLOFENAC, NOVALGIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5319970-2
Sorafenib side effect was reported by a Physician from NETHERLANDS on May 02, 2007. Male patient, 63 years of age, weighting 163.1 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism , tumour pain. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with DURAGESIC, DICLOFENAC, NOVALGIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5532019-1
Sorafenib side effect was reported by a Physician from GERMANY on Nov 21, 2007. Male patient, 63 years of age, weighting 163.1 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism , tumour pain. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with DURAGESIC, DICLOFENAC, NOVALGIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5382834-2
Sorafenib side effect was reported by a Physician from SPAIN on July 05, 2007. Male patient, 61 years of age, weighting 187.4 lb, was diagnosed with metastases to bone, pain
, hyperkalaemia, hypercholesterolaemia, renal failure and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism , respiratory failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CAPECITABINE, ZOMETA, PARACETAMOL, RESINCALCIO, GEMFIBROZILO, HIDROALTESONA. Patient was hospitalized. Patient died on 06/22/2007.Sorafenib Side Effects Report #5281342-7
Sorafenib side effect was reported by a Consumer or non-health professional from ITALY on Mar 20, 2007. Female patient, 60 years of age, weighting 191.8 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with INTERFERON ALPHA. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5479458-5
Sorafenib side effect was reported by a Physician from GERMANY on Sept 25, 2006. Male patient, 59 years of age, was diagnosed with abdominal pain
, constipation , insomnia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SPASFON, BIPERIDYS, METEOSPASMYL, EFFERALGAN CODEINE, DUPHALAC, IMOVANE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5000037-8
Sorafenib side effect was reported by a Physician from FRANCE on May 03, 2006. Male patient, 59 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with SPASFON, BIPERIDYS, METEOSPASMYL, EFFERALGAN, DUPHALAC, IMOVANE, LEXOMIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5146908-3
Sorafenib side effect was reported by a Physician from CANADA on Oct 31, 2006. Male patient, 55 years of age, was diagnosed with constipation
, diarrhoea, pain , decreased appetite and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with PHOSPHATES, IMODIUM, MORPHINE SP, MIRTAZAPINE. Patient died on 10/28/2006.Sorafenib Side Effects Report #5370134-6
Sorafenib side effect was reported by a Physician from CANADA on June 25, 2007. Male patient, 52 years of age, was diagnosed with constipation
, diarrhoea, pain , decreased appetite and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with PHOSPHATES, IMODIUM, MORPHINE SP, MIRTAZAPINE. Patient died on 10/28/2006.